Laboratory Diagnosis of Lupus Anticoagulants
Open accessAbstract
Laboratories are now receiving requests to evaluate patients for the presence of LA. This review will focus on the characterization, clinical associations, and laboratory diagnosis of LA
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The normal range is usually used as a guide for correction but is often inadequate because a circulating anticoagulant with minimally prolonged PT or aPTT may be corrected to normal in a 1:1 mix.
“The normal range usually is used as the guide for correction.However, it often is inadequate because a circulating anticoagulant with a minimally prolonged PT or aPTT may be corrected to normal in a 1:1 mix of PP with CNP. 8”
From A “Percent Correction” Formula for Evaluation of Mixing Studies (2002) · cites this paper as [8]
In “FIG. 1. Approach to prolonged APTT” (page unavailable), the paper says a 1:1 mix of lupus-anticoagulant plasma and normal plasma can correct to within the normal range, particularly with a borderline APTT. It also warns that correction can be hard to distinguish from dilution when the APTT is minimally prolonged. These passages support the concern about using the normal range to judge correction for APTT, but do not establish the same point for PT. (LLM, conf=0.85)
Experimental — accuracy not yet measuredIt was not clear from the publications which of the 1:1 or 4:1 mixing procedures was preferred.
“However, it was not clear from the publications which of the 2 procedures was preferred.”
From A “Percent Correction” Formula for Evaluation of Mixing Studies (2002) · cites this paper as [8]
In “FIG. 1. Approach to prolonged APTT” (page unavailable), the paper says most laboratories use a 1:1 mix, while a 4:1 mix is more sensitive when APTT is minimally prolonged. This supports a condition-dependent distinction rather than one universally preferred procedure, but the paper does not say that the publications left the preference unclear. (LLM, conf=0.78)
Experimental — accuracy not yet measuredThis phenomenon has been termed the lupus cofactor effect.
“This phenomenon has been termed the lupus cofactor effect.8,9”
From A “Percent Correction” Formula for Evaluation of Mixing Studies (2002) · cites this paper as [8]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Harris, E. N., Boey, M. L., Mackworth-Young, C. G., Gharavi, A. E., Patel, B. M., Loizou, S., & Hughes, G. R. V. (1983) · The Lancet · doi:10.1016/s0140-6736(83)91267-9 · Cited by 1,383 · see citing works
Deficiency of protein C in congenital thrombotic disease.
Griffin, J. H., Evatt, B. L., Zimmerman, T. S., et al. (1981) · Journal of Clinical Investigation · doi:10.1172/jci110385 · Cited by 1,263 · see citing works
Inherited Antithrombin Deficiency Causing Thrombophilia
Egeberg, O. (1965) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1656297 · Cited by 1,036 · see citing works
A Survey of 215 Non-Hemophilic Patients with Inhibitors to Factor VIII
Green, D., & Lechner, K. (1981) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1650169 · Cited by 788 · see citing works
Harris, E. N., Gharavi, A. E., Patel, S., & Hughes, G. R. (1987) · PubMed Central · Cited by 724 · see citing works
Carreras, L., Machin, S. J., Deman, R., DEFREYN, G., Vermylen, J., Spitz, B., & Assche, A. V. (1981) · The Lancet · doi:10.1016/s0140-6736(81)92087-0 · Cited by 551 · see citing works
Boey, M. L., Colaco, C. B., Gharavi, A. E., Elkon, K. B., Loizou, S., & Hughes, G. R. (1983) · BMJ · doi:10.1136/bmj.287.6398.1021 · Cited by 508 · see citing works
Cl, C. (1952) · Journal of Clinical Investigation · Cited by 485 · see citing works
Sontheimer, R. D. (1987) · Archives of Dermatology · doi:10.1001/archderm.1987.01660290058016 · Cited by 436 · see citing works
Wolf, F. D., Carreras, L. O., Moerman, P., Vermylen, J., Assche, A. V., & Renaer, M. (1982) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(16)32527-3 · Cited by 411 · see citing works
A Sensitive Test Demonstrating Lupus Anticoagulant and its Behavioural Patterns
Exner, T., RICKARD, K. A., & KRONENBERG, H. (1978) · British Journal of Haematology · doi:10.1111/j.1365-2141.1978.tb03648.x · Cited by 391 · see citing works
INTRAUTERINE DEATH AND CIRCULATING ANTICOAGULANT (“ANTITHROMBOPLASTIN”)
Nilsson, I. M., Åstedt, B., Hedner, U. K. E., et al. (1975) · Acta Medica Scandinavica · doi:10.1111/j.0954-6820.1975.tb04897.x · Cited by 293 · see citing works
Triplett, D. A., Brandt, J. T., Kaczor, D. A., et al. (1983) · American Journal of Clinical Pathology · doi:10.1093/ajcp/79.6.678 · Cited by 276 · see citing works
Self-citationImmunologic and Coagulation Disorders in Chlorpromazine-Treated Patients
Zarrabi, M. H., ZUCKER, S., MILLER, F., DERMAN, R. M., ROMANO, G. S., HARTNETT, J. A., & VARMA, A. O. (1979) · Annals of Internal Medicine · doi:10.7326/0003-4819-91-2-194 · Cited by 230 · see citing works
Lupus Anticoagulants and Thrombosis
Lechner, K., & Pabinger-Fasching, I. (2009) · Haemostasis · doi:10.1159/000215157 · Cited by 195 · see citing works
Circulating Coagulation Inhibitors in the Acquired Immunodeficiency Syndrome
Cohen, A. J., PHILIPS, T. M., & KESSLER, C. M. (1986) · Annals of Internal Medicine · doi:10.7326/0003-4819-104-2-175 · Cited by 184 · see citing works
Cosgriff, T. M., & Martin, B. A. (1981) · Arthritis & Rheumatism · doi:10.1002/art.1780240115 · Cited by 167 · see citing works
Margolis, J. (1958) · Journal of Clinical Pathology · doi:10.1136/jcp.11.5.406 · Cited by 144 · see citing works
Carreras, L. O., Vermylen, J., Spitz, B., et al. (1981) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1981.tb02224.x · Cited by 140 · see citing works
Antibody to cardiolipin, lupus anticoagulant, and fetal death.
Lockshin, M. D., Qamar, T., Druzin, M. L., et al. (1987) · PubMed · Cited by 133 · see citing works
Freyssinet, J.-M., Wiesel, M.-L., Gauchy, J., et al. (1986) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1661553 · Cited by 128 · see citing works
Cutaneous manifestations associated with the presence of the lupus anticoagulant
Grob, J., & Bonerandi, J. J. (1986) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(86)70159-x · Cited by 122 · see citing works
Affinity purified anti-cardiolipin and anti-DNA antibodies.
Harris, E. N., Gharavi, A. E., Tincani, A., Chan, J. K., Englert, H., Mantelli, P., Allegro, F., Ballestrieri, G., & Hughes, G. R. V. (1985) · PubMed · Cited by 122 · see citing works
Green, D., Hougie, C., Kazmier, F. J., et al. (1983) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1657341 · Cited by 121 · see citing works
Human hybridoma lupus anticoagulants distinguish between lamellar and hexagonal phase lipid systems.
Rauch, J., Tannenbaum, M., Tannenbaum, H., et al. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)67567-2 · Cited by 120 · see citing works
Degos' disease: association with anticardiolipin antibodies and the lupus anticoagulant.
Englert, H., Hawkes, C. H., Boey, M. L., et al. (1984) · BMJ · doi:10.1136/bmj.289.6445.576 · Cited by 98 · see citing works
El-Roeiy, A., Gleicher, N., & Friberg, J. (1988) · International Journal of Gynecology & Obstetrics · doi:10.1016/0020-7292(88)90377-3 · Cited by 95 · see citing works
Kelsey, P. R., Stevenson, K. J., & Poller, L. (1984) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1661166 · Cited by 91 · see citing works
Frampton, G., Cameron, J. S., Thom, M. H., et al. (1987) · The Lancet · doi:10.1016/s0140-6736(87)92584-0 · Cited by 89 · see citing works
Lupus-Like Anticoagulants, Modulation of the Protein C Pathway and Thrombosis
Freyssinet, J., & Cazenave, J. (1987) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1645954 · Cited by 81 · see citing works
ANTICARDIOLIPIN ANTIBODIES AND LUPUS ANTICOAGULANT
Harris, E. N., Loizou, S., Englert, H., et al. (1984) · The Lancet · doi:10.1016/s0140-6736(84)91537-x · Cited by 80 · see citing works
The laboratory heterogeneity of lupus anticoagulants.
Triplett, D. A., Jt, B., & Rl, M. (1985) · PubMed · Cited by 78 · see citing works
Self-citationThe sensitivity of different coagulation reagents to the presence of lupus anticoagulants
(1986) · Thrombosis Research · doi:10.1016/0049-3848(86)91499-4 · Cited by 74 · see citing works
Self-citationRustin, M. H. A., Bull, H. A., Machin, S. J., et al. (1988) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12560947 · Cited by 61 · see citing works
Antiphospholipid antibodies: an elderly statesman Dons new garments.
Harris, E. N., Gr, H., & Ae, G. (1987) · PubMed · Cited by 60 · see citing works
LUPUS ANTICOAGULANT IN PREGNANCY
Prentice, R., Gatenby, P., Loblay, R. H., et al. (1984) · The Lancet · doi:10.1016/s0140-6736(84)92938-6 · Cited by 57 · see citing works
Familial Association of the Lupus Anticoagulant
Exner, T., Barber, S., KRONENBERG, H., et al. (1980) · British Journal of Haematology · doi:10.1111/j.1365-2141.1980.tb03814.x · Cited by 56 · see citing works
Systemic Lupus Erythematosus in Childhood A Clinical Study
Zetterström, R. H., & Berglund, G. (1956) · Acta Paediatrica · doi:10.1111/j.1651-2227.1956.tb17690.x · Cited by 56 · see citing works
Antiphospholipid Antibodies and Recurrent Pregnancy Loss
Brown, H. L. (1991) · Clinical Obstetrics & Gynecology · doi:10.1097/00003081-199103000-00006 · Cited by 55 · see citing works
Lupus anticoagulant: a clinical and laboratory study of 100 cases
Jude, B., Goudemand, J., DOLLE, I., Caron, C., Watel, A., Tiry, C., & Cosson, A. (1988) · Clinical & Laboratory Haematology · doi:10.1111/j.1365-2257.1988.tb01152.x · Cited by 53 · see citing works
Mackie, I. J., Colaco, C. B., & Machin, S. J. (1987) · British Journal of Haematology · doi:10.1111/j.1365-2141.1987.tb02358.x · Cited by 50 · see citing works
Lupus anticoagulant in women with multiple spontaneous miscarriage
Howard, M. A., Firkin, B. G., Healy, D. L., et al. (1987) · American Journal of Hematology · doi:10.1002/ajh.2830260208 · Cited by 49 · see citing works
(1986) · New England Journal of Medicine · doi:10.1056/nejm198605083141913 · Cited by 47 · see citing works
Comparison of laboratory tests used for identification of the lupus anticoagulant
Lo, S. C., Oldmeadow, M. J., Howard, M. A., & Firkin, B. G. (1989) · American Journal of Hematology · doi:10.1002/ajh.2830300405 · Cited by 40 · see citing works
Demonstration of a platelet bypass mechanism in the clotting system using an acquired anticoagulant
Firkin, B. G., Booth, P., Hendrix, L. E., et al. (1978) · American Journal of Hematology · doi:10.1002/ajh.2830050202 · Cited by 36 · see citing works
Time Dependency of Lupuslike Anticoagulants
Clyne, L. P. (1988) · Archives of Internal Medicine · doi:10.1001/archinte.1988.00380050066011 · Cited by 35 · see citing works
Lupus anticoagulant in the acquired immunodeficiency syndrome
Bloom, E. J. (1986) · JAMA · doi:10.1001/jama.256.4.491 · Cited by 35 · see citing works
Lockshin, M. D., Druzin, M. L., Goei, S. L., et al. (1986) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-198605000-00014 · Cited by 33 · see citing works
Blocking coagulation inhibitors in children taking penicillin
Orris, D. J., Lewis, J. H., Spero, J. A., et al. (1980) · The Journal of Pediatrics · doi:10.1016/s0022-3476(80)80195-8 · Cited by 29 · see citing works
Hougie, C. (1955) · British Medical Bulletin · doi:10.1093/oxfordjournals.bmb.a069439 · Cited by 28 · see citing works
Liu, H. W., Wong, K., Lin, C. K., Wong, W. S., Tse, P. W. T., & Chan, G. T. C. (1989) · British Journal of Haematology · doi:10.1111/j.1365-2141.1989.tb07687.x · Cited by 26 · see citing works
A clinical study of the lupus anticoagulant
Schleider, M., Nachman, R. L., Jaffe, E., et al. (1976) · Blood · doi:10.1182/blood.v48.4.499.bloodjournal484499 · Cited by 23 · see citing works
Clinical manifestations and laboratory findings in patients with lupus anticoagulants
Kornberg, A., Silber, L., Yona, R., & Kaufman, S. (1989) · European Journal Of Haematology · doi:10.1111/j.1600-0609.1989.tb00253.x · Cited by 21 · see citing works
Immune endothelial-cell injury in heparin-associated thrombocytopenia
MALONE, J. M. (1988) · Journal of Vascular Surgery · doi:10.1016/0741-5214(88)90457-0 · Cited by 20 · see citing works
Circulating Anticoagulant in the Acquired Immunodeficiency Syndrome
Lefrere, J. J., Gozin, D., Modai, J., et al. (1987) · Annals of Internal Medicine · doi:10.7326/0003-4819-107-2-429_2 · Cited by 18 · see citing works
Lupus anticoagulants in children.
Singh, A. K., Rao, K. P. P., Kizer, J., et al. (1988) · PubMed · Cited by 18 · see citing works
The use of the dilute Russell viper venom time for the diagnosis of lupus anticoagulants
Thiagarajan, P., Pengo, V., & Shapiro, S. (1986) · Blood · doi:10.1182/blood.v68.4.869.bloodjournal684869 · Cited by 16 · see citing works
Immunological specificity and mechanism of action of IgG lupus anticoagulants
Pengo, V., Thiagarajan, P., Shapiro, S., et al. (1987) · Blood · doi:10.1182/blood.v70.1.69.bloodjournal70169 · Cited by 13 · see citing works
Bajaj, S., Rapaport, S., Fierer, D. S., et al. (1983) · Blood · doi:10.1182/blood.v61.4.684.bloodjournal614684 · Cited by 11 · see citing works
THE LUPUS ANTICOAGULANT DOES NOT INHIBIT THE RELEASE OF PROSTACYCLIN FROM HUMAN ENDOTHELIAL CELLS
Petraiuolo, W., Bovill, E. G., & Hoak, J. C. (1987) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1644228 · Cited by 9 · see citing works
The Acquired Immunodeficiency Syndrome and Lupus Anticoagulant
Haire, W. D. (1986) · Annals of Internal Medicine · doi:10.7326/0003-4819-105-2-301_2 · Cited by 7 · see citing works
Rosove, M., Ismail, M., Koziol, B., et al. (1986) · Blood · doi:10.1182/blood.v68.2.472.bloodjournal682472 · Cited by 5 · see citing works
ANTICARDIOLIPIN ANTIBODIES ASSOCIATED WITH HTLV‐III INFECTION
Canoso, R. T., Zon, L. I., & Groopman, J. E. (1988) · British Journal of Haematology · doi:10.1111/j.1365-2141.1988.tb06208.x · Cited by 5 · see citing works
LUPUS ANTICOAGULANT AND REPEATED ABORTIONS: A CASE- CONTROL STUDY
Barbui, T., Cortelazzo, S., Galli, M., et al. (1987) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1643655 · Cited by 3 · see citing works
[Pathogenic significance of circulating anticoagulants in human immunodeficiency virus infection].
Taillan, B., Jg, F., Roul, C., et al. (1989) · PubMed · Cited by 1 · see citing works
Flagged first, then by citations
Research works printed but not linked: 1
- Feinstein DI: Acquired inhibitors against factor VIII and other clotting proteins. In: (Eds) Colman RW, J Hirsh, VJ Marder, EW Salzman: Hemostasis and Thrombosis, Basic Principles and Clin- ical Practice. JB Lippincott, Philadelphia, 1982, pp. 563-576.
Cited by
Sorted by citations
A “Percent Correction” Formula for Evaluation of Mixing Studies
Chang, S.-H., Tillema, V., & Scherr, D. (2002) · American Journal of Clinical Pathology · doi:10.1309/rrek-8l6m-d2kc-hwlh · Cited by 67 · see citing works
- Authors
- Triplett, D.
- Affiliations
- Indiana University School of Medicine (US)
- Corresponding author
- Triplett, Douglas
- Venue
- Seminars in Thrombosis and Hemostasis
- Publisher
- Georg Thieme Verlag KG
- Published
- 1990-04
- Volume
- 16
- Issue
- 02
- Pages
- 182-192
- ISSN
- 0094-6176 (ISSN-L)
- 1098-9064
- OpenAlex
- W2045499358
- Cited by
- 39
- References
- 65
- Citations by year
- 2018: 1 · 2015: 1 · 2014: 2
- FWCI
- 0.62
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Seminars in Thrombosis and Hemostasis (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
- Health Sciences › Medicine › Hematology › Blood Coagulation and Thrombosis Mechanisms
- Health Sciences › Medicine › Surgery › Heparin-Induced Thrombocytopenia and Thrombosis
- Keywords
- lupus anticoagulant, laboratory diagnosis, antiphospholipid antibodies, clinical associations, thrombosis, hemostasis
- MeSH terms
- Autoantibodies, Blood Coagulation Disorders, Blood Coagulation Factors, Humans, Thromboembolism, Lupus Coagulation Inhibitor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review